XML 32 R20.htm IDEA: XBRL DOCUMENT v3.23.2

Revenue Recognition (Tables)

6 Months Ended

Jun. 30, 2023

Revenue Recognition [Abstract]

Schedule of Disaggregated Revenue

We disaggregate our net sales by business and geographic location for each of our segments as we believe it best depicts how the nature, amount, timing and certainty of our net sales and cash flows are affected by economic factors.

Beginning in the first quarter 2023 we consolidated Other MedSurg and Neurotechnology into Endoscopy as Other MedSurg and Neurotechnology (primarily Sustainability Solutions) has been fully integrated into our Endoscopy business. Endoscopy includes sales related to Other of $87 and $77 for the three months 2023 and 2022 and $168 and $146 for the six months 2023 and 2022. We have reflected these changes in all historical periods presented.

Net Sales by Business
			Three Months									Six Months
			2023			2022						2023			2022
MedSurg and Neurotechnology:
Instruments			$	630		$	563					$	1,205		$	1,091
Endoscopy			705			677						1,403			1,284
Medical			841			666						1,619			1,330
Neurovascular			311			306						595			607
Neuro Cranial			373			337						728			660
			$	2,860		$	2,549					$	5,550		$	4,972
Orthopaedics and Spine:
Knees			$	562		$	500					$	1,128		$	964
Hips			393			364						768			691
Trauma and Extremities			766			676						1,535			1,361
Spine			296			290						580			569
Other			119			114						213			211
			$	2,136		$	1,944					$	4,224		$	3,796
Total			$	4,996		$	4,493					$	9,774		$	8,768

Net Sales by Geography
			Three Months 2023									Three Months 2022
			United States			International						United States			International
MedSurg and Neurotechnology:
Instruments			$	512		$	118					$	451		$	112
Endoscopy			568			137						548			129
Medical			682			159						536			130
Neurovascular			123			188						113			193
Neuro Cranial			306			67						281			56
			$	2,191		$	669					$	1,929		$	620
Orthopaedics and Spine:
Knees			$	406		$	156					$	368		$	132
Hips			249			144						230			134
Trauma and Extremities			559			207						489			187
Spine			221			75						209			81
Other			85			34						86			28
			$	1,520		$	616					$	1,382		$	562
Total			$	3,711		$	1,285					$	3,311		$	1,182

Net Sales by Geography
			Six Months 2023									Six Months 2022
			United States			International						United States			International
MedSurg and Neurotechnology:
Instruments			$	962		$	243					$	865		$	226
Endoscopy			1,132			271						1,034			250
Medical			1,294			325						1,061			269
Neurovascular			241			354						223			384
Neuro Cranial			595			133						545			115
			$	4,224		$	1,326					$	3,728		$	1,244
Orthopaedics and Spine:
Knees			$	822		$	306					$	713		$	251
Hips			485			283						432			259
Trauma and Extremities			1,113			422						976			385
Spine			433			147						409			160
Other			146			67						158			53
			$	2,999		$	1,225					$	2,688		$	1,108
Total			$	7,223		$	2,551					$	6,416		$	2,352

Contract with Customer, Contract Asset, Contract Liability, and Receivable

Changes in contract liabilities during the six months 2023 were as follows:

			June 2023
Beginning contract liabilities			$	741
Revenue recognized from beginning of year contract liabilities			(230)
Net advance consideration received during the period			273
Ending contract liabilities			$	784

X

- Definition

Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 10
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045

+ Details

Name:	us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenueRecognitionAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration